 |
|
|
|
|
|
 |
Drug Discovery |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Genomics World Markets
|
May 2008 |
£2280 |
Outsourcing in Drug Discovery, 3rd Edition
|
May 2008 |
£2010 |
Blood Cancer Drug Discoveries
What the Future Holds
|
April 2008 |
£1295 |
Drug Approval Trends at the FDA and EMEA
Process Improvements, Heightened Scrutiny and Industry Response
|
April 2008 |
£1995 |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
|
January 2008 |
£1499 |
Gastrointestinal Drug Discoveries
|
January 2008 |
£995 |
Premium Company Profile: Acambis PLC
|
November 2007 |
£265 |
Drug Development Opportunities In China
Regulation, Key Players And Initiatives For Domestic And International Markets
|
September 2007 |
£1495 |
Drug Discovery Tools for High-Content Analysis
|
July 2007 |
£1340 |
Conducting Clinical Trials in Emerging Markets
|
January 2007 |
£2395 |
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Equipment, Technologies and Companies, 2006-2011
|
January 2007 |
£1105 |
CNS Drug Discoveries
What the Future Holds
|
November 2006 |
£1995 |
CNS Drug Discoveries: Multiple Sclerosis
|
November 2006 |
£795 |
Merging of Pathway Analysis into the Mainstream; The
Indicators of Progress Sighted
|
August 2006 |
£220 |
High-Level Systems Biology Modeling in Drug Development
|
June 2006 |
£1920 |
Plant-Derived Drugs: Products, Technology, Applications
|
June 2006 |
£3255 |
Cardiovascular Drug Discoveries
What the Future Holds
|
May 2006 |
£1995 |
Contract Drug Discovery Industry
Sector Snapshot
|
March 2006 |
£335 |
Drug Repositioning
A market analysis
|
March 2006 |
£1095 |
Combination Therapies
Benefits and Challenges in Drug, Device, and Biologicals Development
|
October 2005 |
£1945 |
Cancer Drug Discoveries
What the Future Holds
|
August 2005 |
£1995 |
Powering Discovery through Target Evaluation
Moving Beyond the Validation Paradigm
|
August 2005 |
£1950 |
SAFE Initiative Takes Center Stage at DIA's 41st Annual Meeting
|
July 2005 |
£835 |
Overview of Molecular Imaging Technologies in the Drug Development Process
|
July 2005 |
£1945 |
Event Analysis and Response Service: Cox-2s
Cox-2 Crisis Dents Big Pharma Confidence
|
June 2005 |
£6000 |
Industrialization of Drug Discovery
|
May 2005 |
£80 |
Impact of Nanotechnology in Drug Discovery; The
|
March 2005 |
£1140 |
Virtual Screening in Drug Discovery
|
March 2005 |
£85 |
Cancer Vaccines Fantasy or Future?
|
February 2005 |
£1635 |
The Outlook For RNAi
Accelerating drug discovery and the development of RNAi therapeutics
|
January 2005 |
£1495 |
Emerging Drug Discovery Technologies
Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
|
January 2005 |
£1495 |
Migraine
A market focus
|
August 2004 |
£885 |
Pharmaceutical Discovery & Development Report
|
June 2004 |
£185 |
Model Animal Systems
Emerging Applications and Commercial Opportunities in Drug Discovery and Development
|
June 2004 |
£1946 |
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress
|
May 2004 |
£840 |
Novel Targets in Drug Discovery
A new era in therapy
|
April 2004 |
£595 |
Part 11 and Drug Development
A Q&A Reference Guide (March, 2004)
|
March 2004 |
£10 |
Stephens' Detection of New Adverse Drug Reactions
5th Edition
|
December 2003 |
£110 |
Drug Discovery Strategies and Methods
|
November 2003 |
£100 |
Rheumatoid Arthritis: Emerging drug discovery targets
And therapeutic candidates
|
October 2003 |
£375 |
Burger's Medicinal Chemistry and Drug Discovery
6 Volume Set
|
March 2003 |
£1331 |
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
|
August 2001 |
£1105 |
Drug Discovery Technology
A Combination Of Opportunities
|
June 2001 |
£1615 |
The US Bio-Chip Market for Pharmaceutical Drug Discovery
Technology, Strategic Alliance, Patent Dispute and Market Update - 2002
|
May 2001 |
£735 |
Drug Development Programme Management
|
October 2000 |
£140 |
|
|
|
|
